Month: September 2011

BIOVAL organizes a workshop on the management of health enterprises in international markets on 23 September

|

BIOVAL organizes a workshop on the management of companies in international markets health on 23 September

23 September

BIOBREAKFAST:

health in international markets business management

BIOVAL celebrated September 23 the 4th edition of the cycle of conferences BioBreakfast with a practice day with Alexander Portilla, Business Excellence Manager for Abbott Laboratories, a great expert in the international market for health.

With more than 13 years of experience in Abbott, Alexander Portilla has a very deep knowledge of what is necessary to succeed and be competitive in this sector and will provide a perspective different, especially interesting for new entrepreneurs scientific and biotechnological SMEs which, in addition to mastering the scientific issues of their projectsthey need to improve aspects of management.

Currently it is key to have a global vision for access to sources of funding, find better customers and professionalize the work teams. Alejandro Portilla will talk about his experience so much Abbott as his collaborations with young companies with the purpose of providing keys to improve the competitiveness of the Bioregion of the Valencian Community.

Abbott is a multinational company dedicated to the health care through the discovery, development, manufacture and marketing of pharmaceuticals and medical products, ranging from nutrition to medical devices and Diagnostics. Abbott products cover all phases of the process of the disease (prevention, diagnosis, treatment and healing) and are present throughout the cycle of life of people (infant, childhood, adolescence, maturity and old age).

Free assistance with prior registration: cursos@bioval.org or 902 88 99 90.

BIOVAL

BIOVAL is the Association that brings together more than 50 biotechnology companies in the Valencian Community, research centres and technological universities and hospitals whose research activity is linked to the biotechnology BIOVAL was formed in late 2006 to develop and take advantage of the opportunities for innovation in the biotechnology sector, as a vector of economic and social growth in the Valencian Community.

Read More

Teknon applied cell therapy against chronic back pain

|

Teknon applied cell therapy against chronic low back pain

– This is a non invasive technique which preserves the spinal mobility

-Teknon researchers lead clinical trials in cell therapy

Barcelona, 2011-September researchers of the unity of tissue regenerative therapy of Centro Médico Teknon, have found the suitable use of adult stem cells in the treatment of certain degenerative intervertebral disc disorders that cause of chronic low back pain. The results of the study have been published this month in the influential American scientific magazine “ Transplantation ” with more than 25,000 annual appointments.

Low-back pain is the second leading cause of low labour and responsible for the annual loss of 700,000 hours according to data provided by the Directorate General for research and innovation of the European Commission. It affects 67 million people in the European Union, of which 5 million are Spanish. It is estimated that 75% of the population suffers back pain at some point in his life; exceeds 90% before 3 months but in 5-10% is cronifica.

One of the most common causes of chronic low back pain is the degeneration of the intervertebral disc. In most cases this process is asymptomatic but when refractory pain must resort to various surgical procedures such as the Suppression of the movement of the affected area. Spain carried a 1,000 vertebral fixation or Arthrodesis annually and about 40,000 in the USA.

Against this alternative, the researchers designed a pilot study on 10 patients presenting with back pain chronic, attributable to degeneration of the lumbar disc, which injected a certain dose of stem cells. The cells were obtained from the bone of the pelvis of the same patients and cultivated at the Institute of biology Molecular Genetics, Center of the University of Valladolid and the Centro Superior de Investigaciones Científicas.

After three weeks of cultivation the resulting cellular product inoculated percutaneously and radioscopic control in the affected spinal disc. Both the procedure for obtaining cell as application is made under light sedation and local anesthesia and they do not require hospital admission.

Patients were followed and evaluated for a year, proving that they showed a significant improvement in pain and disability in 9 of the 10 treated cases. The effectiveness, comparing it with the current surgical solutions, was similar or even higher, with the

advantage that an intervention is non-invasive, simple and conservative that preserves the Biomechanics of spinal vertebral.

Currently the Spanish Agency of medicines and health products regularly authorizes Centro Médico Teknon researchers to keep practicing this cell therapy in selected cases, and always under his control.

All clinical trials and subsequent compassionate use treatments carried out by the unit has been under the approval and oversight of the Ethics Committee and Teknon clinic research under the current legal regulations, both the Department of health and the Ministry of health, Social Affairs and equality.

Trial took place in accordance with the agreement signed between the unity of tissue regenerative therapy of Centro Médico Teknon and the Instituto de Salud Carlos III, agency of the Ministry of science and innovation, was framed in the Plan of advanced therapies, which led to the Ministry of health in 2007 and is the result of the research network which enables the TerCel network of the named Instituto Carlos III, also being a sample of the benefits of scientific collaboration between public and private entities that was attended by researchers from Centro Médico Teknon, the IBGM of Valladolid and Egarsat (mutual of occupational accidents and diseases of social security).

Unit therapy regenerative tissue of Centro Médico Teknon, co-directed by doctors Lluís Orozco Delclós and Robert Rich Soler is a pioneer in research and treatment with adult stem cells. It collaborates with public and private institutions, as well as optional in various medical specialties to determine scientific evidence of the benefit of cell therapy. Seven clinical trials and more than 130 patients treated with aims of bone regeneration in consolidation, regeneration of cartilage defects joint in osteoarthritis and intervertebral disc regeneration, behind this therapeutic potential and open up a broad spectrum of future applications.

Read More

87% Of women Note specific changes in their skin during menopause

|

87% of women note changes specific to your skin during menopause

European survey / the skin in menopause

-menopause affects skin showing more dry, dehydrated and wrinkled, according to a European study presented at the World Congress of medicine Antienvejecimiento Montecarlo.

-more than half (54%) currently don’t feel secure of their appearance and their skin.

-En Spain 18% of women has been submitted or would undergo injectable facial treatments to improve the appearance of your skin.

Madrid, September of 2011. Menopause is the transition period in the life of the woman in which the ovaries stop producing eggs produce less estrogen and progesterone. The physiological changes begin prior to menopause and vary considerably in extent and extension for every woman, affecting different organs including skin.

The objective of the survey “ the skin in menopause ”, promoted by Allergan and presented at the World Congress of medicine Antienvejecimiento of Monte Carlo, and in Great Britain, France, Germany, Italy and Spain, has been the of an overview on the perception of the European on your skin before and after menopause.

The survey, completed by over 1,074 European women, revealed that 87% noticed specific changes in their skin as a result of menopause, noticing it more dry (37%), dried (19%) and wrinkled (19%).

The effects of menopause on the skin are initially unknown female

The middle ages in which the woman starts the climacteric is 47 years, but the effects of this are beginning to appreciate before. Psychological and physical effects begin to occur in women during this period, and the appearance of the skin is one of them. According to results of the survey, only 6% of women have total confidence in the appearance of their skin during these years, compared with the initial 44% who saw “ very well for her age ” before menopause.

However, according to the study 36 per cent of those surveyed unknown possible implications on your skin during menopause, while 73% include hot flashes as a direct result of this stage, ignoring the possible changes that may experience your skin.

More wrinkles and facial lines and less elasticity

Reply to the question of what have been the major changes that have been warned on his face due to menopause, 54% of respondents agreed the increase of wrinkles and facial lines, a fact which confirms the DRA. Petra Petra Navarro, medical specialist in aesthetic medicine and Medical Director of Instimed, a Centre for aesthetic medicine with twenty years of experience. Moreover, points out a 46 per cent loss of elasticity in the skin is one of the major changes that have experienced. The decline of the softness (29%), change in hue of the skin (27%) or a change in the size of the pores (21%) are some of the alterations that are highlighted in the survey.

According to Dr. Navarro, “ 90% of women over 45 years old who attend my consultation, have a skin losing thickness and elasticity, and many of them, begin to have spots associated with the age and suffering the first signs of sagging, in other words, a progressive sagging of the skin, which becomes accentuated from 50. Fortunately, today we have different technical medical-aesthetic that will help us combat the passage of the age: Mesotherapy, peeling, fillers, laser, radio frequency, etc., botulinum toxin, making our patients age with good face ”

after these results, it is logical to think that women in this age range have heightened concern about their appearance. So says 62% of respondents to increase their habits and beauty treatments, that they feel less safe (46%) and less sexy (48%).

1 of every 5 surveyed European has been submitted or considered undergo injectable facial treatments

In Spain, between beauty treatments that stand out those surveyed can highlight a 12 per cent has been submitted or considered undergo injectable treatments to improve the appearance of your skin. Anti-aging creams are more adept together with 76% that already use. Also, the contribution of greater hydration by injection is also considered by 10% of the Spanish.

The overall satisfaction of those surveyed who already undergo beauty treatments is very high, says 58% of them, being 75% that had started earlier with the same view of the excellent results.

Read More

The medical school of Zaragoza presents its training program for this course

|

the College of physicians of Zaragoza presents its training program for the course

Zaragoza, 2011-September the College of physicians of Zaragoza unveils its training offer for this course. The training programme includes courses online, in area of clinical and non clinical skills, and face-to-face courses.

The programme has been forwarded to all members, through a complete guide to little more than 100 pages, which provides detailed information on each of the courses or seminars, standards for the registration or obtaining certificates.

Enrolment, since last year can be made via the internet, via the College website that offers this comfortable possibility to the members, who need no longer go to the formalities of registration to the training center

Program

Face-to-face courses relate to specific clinical skills areas: cardiology, surgery, dermatology, encocrinología and nutrition, Gynecology, hematology, infectious, pneumology, Neurology, ophthalmology, Pediatrics, radiology, rheumatology and traumatology.

Also to areas of common clinical competencies: palliative, homeopathy, laboratory, pain and emergency treatment.

The programme also includes other areas of no clinical common competences, with references to courses on emotional intelligence and leadership for health professionals, or the management of absenteeism.

In addition, language courses, this year incorporates German (with English and French) and in computer science, offers the possibility of improving the knowledge of the web 2.0 applications, but also how to do a blog or know the medical internert or master the techniques of video, digital image and sound…

In total, the medical school of Zaragoza offers a program of training medical continued with 64 courses, of which 7 are online, and whose teaching period extends from October to may.

In the presentation of the Guide, the President of the College of doctors of Zaragoza, Dr. Enrique la Figuera, points out that “ competition in the framework of the continuous medical training is a necessity in our collective, and the institutions must take steps to develop training activities of quality ”. Also reiterates that, for the academic year 2011 / 2012 “ from school we continue investing in the continuous training, and we propose to make one still greater organizational and economic effort, to develop the ambitious program presented in this document and to continue to offer new opportunities, and innovative training activities are incorporated into the College offer online ”. Finally, the President of the College of physicians of Zaragoza says that “ doing so, we continue our positive developments in this important field of our activity, and provide our members access to a quality training under the best conditions of flexibility and diversity, allowing them to combine study and the maximum working ”.

For more information about courses, see the Guide at the following web link: http://bit.ly/r5FQ2K

Read More

Study a new tool to facilitate the individualization of treatment in patients with hepatitis C

|

in study a new tool to facilitate the individualization of treatment in patients with hepatitis C

experts gather in Barcelona at the meeting of researchers on the study HRUBEJ

-healing of the sick rates have increased from 12% to 70%, in just a few years, thanks to standard treatment, pegylated interferon + Ribavirin

– there are new factors prognosis that help predict the chances of cure for patients before starting treatment, thereby facilitating the identification of the

-some of these factors depend on the virus (such as viral load and genotype) and others (the degree of liver disease) patient(: fibrosis and metabolic disorders). If analysed, can determine the chances of cure of the patients, ranging from a 0 – 10% up to 90-100%

-more than 80 hospitals participating in the study HRUBEJ and currently has almost recruited half of the sample. This study seeks to develop a tool to predict the impact of these prognostic factors and identify those patients most likely response

-the study will respond to what the real impact of the IL28B in the treatment of hepatitis C with standard therapy; what subgroup of patients presents more than 80% cure rate andtherefore hardly improved with treatments based on triple therapy; and have a tool to make decisions when new drugs are available in the market

Barcelona, September 2011- hepatitis C is a disease very prevalent that affects millions of people around the world. Despite this, Dr. Ricard Solà, head of the section of hepatology of the Hospital of the sea Barcelona, underscores that, “ unlike other viruses, hepatitis C can cure ”. ” Moreover adds Dr. Manuel Romero, head of the service of digestive system of the Hospital of Valme in Seville – is a condition that you we have been gaining ground slowly thanks to standard therapy, pegylated interferon + Ribavirin and new antiviral ”.

We live in a scenario where the rates of healing of the sick have increased 12% to 70% in just a few years, “ and where new factors Outlook help us predict the chances of cure for patients before starting the treatment ”, indicates Dr. Romero.

Many parameters that help make treatments, specialists are known “ as, for example, according to the kinetics of the virus during treatment, taking into account the first time that the virus becomes negative ”, explains Dr. Solá. “ Some of these factors depend on the virus (such as viral load and genotype) and others of the patient (the degree of liver disease: fibrosis and metabolic disorders). If analyzed, can determine the chances of cure for patients ranging from 0 – 10% up to 90-100% ”, argues Dr. Romero.

Recently, it has discovered a polymorphism of each person who predicts quite accurately the chances of cure of each individual. “ El IL28B helps us discover those patients with double therapy can cure almost 90% of potential ”, says Dr. Solá. “ Therefore, – adds – joins the other indicators which are of vital importance as they help us to explain it to the patient the possibilities of cure, and also to plan the treatment ”.

In this context, arises the need to develop a tool to predict the impact of these prognostic factors and to identify those patients most likely response. With these objectives was born the HRUBEJ study, already underway, and with half of the recruited patients and more than 80 hospitals in all Spain already involved. “ Our goal is to reach the sample to be able to optimize therapies and, therefore, resources ”, says Dr. Romero.

Yesterday was held in Barcelona the meeting of researchers to analyze the situation of the study, the purposes and project goals or to meet. “ Believe that with the HRUBEJ study we respond to what the real impact of the IL28B in the treatment of hepatitis C with standard therapy; What subgroup of patients presents more than 80%, and therefore cure rate, hardly improved with treatments based on triple therapy; and have a tool to make decisions when new drugs are available in the market ”, indicates Dr. Romero. “ Moreover, adds Dr. Solá – the HRUBEJ may also disclose who are patients who have the best genotype and the best chance of cure and not heal; and who are taking a worse genotype, still heal. This will determine the best individualized, based on double or triple therapy treatment, and the time of each ”.

“ A major suspicions that we have is that in patients who have positive genotype, patients that are easy to cure, heal just with the usual standard therapy, pegylated interferon + Ribavirin, patients receiving triple therapy, supposing, moreover, a significant increase in the cost of treatment and more adverse effects. This is one of the aspects that we want to show in this study, the rate of healing in patients with favourable genotype is so high that it is very difficult to her can overcome a new combination ”, concludes Dr. Romero.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips